TIDMCIR

RNS Number : 1742D

Circassia Pharmaceuticals Plc

25 April 2017

Circassia Announces Non-Executive Director Retirements

Oxford, UK - 25 April 2017: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR) today announces the retirement of Non-Executive Directors Charles Swingland and Dr Tim Corn from its Board. Both have informed the Company that after serving for more than 10 years they will remain on the Board until the Company's Annual General Meeting on 26 May 2017, at which they will not seek re-election.

Dr Francesco Granata, Circassia's Chairman, commented: "On behalf of the Board and the wider Company, I would like to thank both Charles and Tim for their significant contributions to the development of Circassia over the last 10 years. They have brought great experience and wisdom to the role, and their advice and counsel has been highly valued. Both the Board and Company will miss their valuable input and we wish them well."

-Ends-

For further information, please contact:

 
 Circassia 
  Steve Harris, Chief Executive           Tel: +44 (0)1865 405 560 
  Officer 
  Julien Cotta, Chief Financial 
  Officer 
  Rob Budge, Corporate Communications 
 FTI Consulting                         Tel: +44 (0) 20 3727 1000 
  Ben Atwell / Simon Conway 
  / Mo Noonan

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOALLFEESAISFID

(END) Dow Jones Newswires

April 25, 2017 02:02 ET (06:02 GMT)

Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Circassia Charts.
Circassia (LSE:CIR)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Circassia Charts.